Overview

Sildenafil and Uteroplacental Perfusion

Status:
Unknown status
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sildenafil is effective and safe in the treatment of fetal growth restriction.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tehran University of Medical Sciences
Treatments:
Sildenafil Citrate